NEWS
News Articles
COVID-19 Test Availability Rapidly Scales Up
Industry Rallies To Boost Production WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) today released the following statements by Scott Whitaker, AdvaMed president and CEO, and Susan Van Meter, executive director of AdvaMedDx, regarding the medtech industry’s ongoing response to the coronavirus pandemic: “Within just the last few weeks, 17 diagnostics companies have received FDA Emergency…
Read MoreCoronavirus (COVID-19) Pandemic: Supply Chain Stabilization Task Force
The Supply Chain Stabilization Task Force is executing a whole-of-America approach to address limited supply of critical protective and life-saving equipment. Through a four-prong approach of Preservation, Acceleration, Expansion and Allocation, FEMA is bringing the full capacity of the Federal government to bear to find solutions to protect the American people and defeat COVID-19. Locating…
Read MoreEvox Therapeutics Receives up to €800M from Takeda To Tackle Rare Diseases
The Japanese pharmaceutical company Takeda has struck a deal worth up to €803M with UK biotech Evox Therapeutics to develop rare disease treatments delivered to cells via nanocapsules called exosomes. As part of the deal, Evox will use its proprietary technology platform to modify and load RNA and protein drugs into exosomes and target the…
Read MoreGEORGIA STATE SCIENTISTS ARE JOINING THE RACE TO UNRAVEL HOW THE NEW CORONAVIRUS OPERATES — AND FIND EFFECTIVE TREATMENTS.
Schools closed. Workers logging in remotely. Streets empty. Businesses shuttered. The coronavirus pandemic is upending daily life throughout the world, and one of the biggest unknowns is “for how long?” The answer to that question depends on a number of factors, including how quickly scientists can learn more about how the virus, known as SARS-CoV-2,…
Read MoreFDA Grants VERO Biotech Expanded Access Emergency Use for the Treatment of Patients with COVID-19, with the GENOSYL® DS, the First and Only FDA-Approved Tankless System for the Delivery of Inhaled Nitric Oxide
The recently FDA-approved GENOSYL® inhaled nitric oxide may have pulmonary and antiviral benefits in treating pulmonary hypertension and acute infectious diseases associated with the novel coronavirus1 GENOSYL® DS facilitates outpatient use of inhaled nitric oxide in the treatment of cardiopulmonary symptoms associated with COVID-19 Read original article here. March 26, 2020 – VERO Biotech LLC, an Atlanta,…
Read MoreNIH, CDC to See Funding Boosts in Stimulus Bill
NIH is slated to receive an additional $945 million to combat Covid-19 under the Senate’s economic relief package, bringing the agency’s total influx of coronavirus money to nearly $1.8 billion. The Senate is aiming to vote Wednesday on the spending plan, after reaching a deal with the White House. It’s the third coronavirus response legislation, and…
Read More